AVAPRITINIB and HEADACHE

Overview

HEADACHE is the #8 most commonly reported adverse reaction for AVAPRITINIB, manufactured by Blueprint Medicines Corporation. There are 489 FDA adverse event reports linking AVAPRITINIB to HEADACHE. This represents approximately 1.9% of all 25,335 adverse event reports for this drug.

Patients taking AVAPRITINIB who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HEADACHE is a less commonly reported adverse event for AVAPRITINIB, but still significant enough to appear in the safety profile.

Other Side Effects of AVAPRITINIB

In addition to headache, the following adverse reactions have been reported for AVAPRITINIB:

• FATIGUE — 1,594 reports
• OFF LABEL USE — 1,218 reports
• NAUSEA — 1,104 reports
• DIARRHOEA — 937 reports
• SWELLING FACE — 498 reports
• DIZZINESS — 492 reports
• MEMORY IMPAIRMENT — 490 reports
• VOMITING — 482 reports
• ASTHENIA — 443 reports
• PLATELET COUNT DECREASED — 437 reports

Other Drugs Associated with HEADACHE

The following drugs have also been linked to headache in FDA adverse event reports:

Does AVAPRITINIB cause HEADACHE?

HEADACHE has been reported as an adverse event in 489 FDA reports for AVAPRITINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HEADACHE with AVAPRITINIB?

HEADACHE accounts for approximately 1.9% of all adverse event reports for AVAPRITINIB, making it a notable side effect.

What should I do if I experience HEADACHE while taking AVAPRITINIB?

If you experience headache while taking AVAPRITINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages